Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 18,245 | -57,466 | -67,138 | -31,292 | -10,284 |
| Depreciation Amortization | 9,312 | 6,839 | 9,175 | 3,407 | 1,311 |
| Income taxes - deferred | 1,401 | -223 | -1,877 | -8,736 | N/A |
| Accounts receivable | -12,643 | -14,930 | -6,218 | -4,631 | 1,663 |
| Accounts payable and accrued liabilities | -4,372 | 5,707 | 582 | -182 | 169 |
| Other Working Capital | -14,125 | -6,630 | -7 | -4,102 | 9,148 |
| Other Operating Activity | 67,048 | 61,077 | 23,828 | 26,553 | 7,858 |
| Operating Cash Flow | $64,866 | $-5,626 | $-41,655 | $-18,983 | $9,865 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -21,829 | -2,575 | -134,689 | N/A | N/A |
| PPE Investments | -28,308 | -13,608 | -5,437 | -3,473 | -4,748 |
| Net Acquisitions | N/A | N/A | -26,419 | -63,184 | N/A |
| Investing Cash Flow | $-50,137 | $-16,183 | $-166,545 | $-66,657 | $-4,748 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | -97 | -142 | -122 | -8 | -27,359 |
| Common Stock Issued | 4,998 | 2,978 | 3,325 | 6,546 | 333,249 |
| Other Financing Activity | -8,762 | -5,134 | -1,688 | -1,117 | 0 |
| Financing Cash Flow | $6,139 | $-2,298 | $1,515 | $5,421 | $305,890 |
| Beginning Cash Position | 98,841 | 122,948 | 329,633 | 409,852 | 98,845 |
| End Cash Position | 119,709 | 98,841 | 122,948 | 329,633 | 409,852 |
| Net Cash Flow | $20,868 | $-24,107 | $-206,685 | $-80,219 | $311,007 |
| Free Cash Flow | |||||
| Operating Cash Flow | 64,866 | -5,626 | -41,655 | -18,983 | 9,865 |
| Capital Expenditure | -28,326 | -13,621 | -5,632 | -3,483 | -4,751 |
| Free Cash Flow | 36,540 | -19,247 | -47,287 | -22,466 | 5,114 |